http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002088081-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e43b4ca6b41ce9f54c9a895d474c81a |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 |
| filingDate | 2000-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_681a59838483700a8d73ded90d20458c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_248aeca7d79fec041c3500605bc085f2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3c753a7936487d1a784194edcacdc47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31a91a3b471b894b9124b5967bee0b51 |
| publicationDate | 2002-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2002088081-A |
| titleOfInvention | Novel naphthyridine derivative or pharmacologically acceptable salt thereof |
| abstract | (57) [Summary] [PROBLEMS] A novel tachykinin receptor antagonist is desired. A novel naphthyridine derivative represented by the following general formula (1) or a pharmacologically acceptable salt thereof is provided. Embedded image For example, in the formula, R1, R2, R3, R4, R5, R6 and R7 each independently represent a hydrogen atom, a lower alkyl group, a hydroxyl group, It represents a lower alkoxy group or a lower acyloxy group. Q is N An amino-protected compound represented by RaCORb; L is an unsubstituted or oxygen atom; X and Y are ethylene and methylene groups; and Z is a phenyl group or a substituted phenyl group. A represents a hydrogen atom, a lower alkyl group, or the like. G represents an acyl group. As a specific example, 10-acetylamino-2-[(4- (N-benzoyl-N-methyl) amino-3- (3,4-dichlorophenyl) butyl]- 1,2,3,4-tetrahydro-benzo [b] [1, 6] naphthyridine 5-oxide. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011116867-A1 |
| priorityDate | 2000-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 132.